Literature DB >> 15651087

An application of propensity score matching using claims data.

John D Seeger1, Paige L Williams, Alexander M Walker.   

Abstract

BACKGROUND: Confounding by indication is a common problem in pharmacoepidemiology, where predictors of treatment also have prognostic value for the outcome of interest. The tools available to the epidemiologist that can be used to mitigate the effects of confounding by indication often have limits with respect to the number of variables that can be simultaneously incorporated as components of the confounding. This constraint becomes particularly apparent in the context of a rich data source (such as administrative claims data), applied to the study of an outcome that occurs infrequently. In such settings, there will typically be many more variables available for control as potential confounders than traditional epidemiologic techniques will allow.
METHODS: One tool that can indirectly permit control of a large number of variables is the propensity score approach. This paper illustrates the application of the propensity score to a study conducted in an administrative database, and raises critical issues to be addressed in such an analysis. In this example, the effect of statin therapy on the occurrence of myocardial infarction was examined, and numerous potential confounders of this association were adjusted simultaneously using a propensity score to form matched cohorts of statin initiators and non-initiators.
RESULTS: The incidence of myocardial infarction observed in the statin treated cohort was lower than the incidence in the untreated cohort, and the magnitude of this effect was consistent with results from randomized placebo controlled clinical trials of statin therapy.
CONCLUSIONS: This example illustrates how confounding by indication can be mitigated by the propensity score matching technique. Concerns remain over the generalizability of estimates obtained from such a study, and how to know when propensity scores are removing bias, since apparent balance between compared groups on measured variables could leave variables not included in the propensity score unbalanced and lead to confounded effect estimates. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15651087     DOI: 10.1002/pds.1062

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  77 in total

Review 1.  Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.

Authors:  Goodarz Danaei; Mohammad Tavakkoli; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2012-01-05       Impact factor: 4.897

2.  Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples.

Authors:  Peter M Wahl; Joshua J Gagne; Thomas E Wasser; Debra F Eisenberg; J Keith Rodgers; Gregory W Daniel; Marcus Wilson; Sebastian Schneeweiss; Jeremy A Rassen; Amanda R Patrick; Jerry Avorn; Rhonda L Bohn
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

Review 3.  Bridging the inferential gap: the electronic health record and clinical evidence.

Authors:  Walter F Stewart; Nirav R Shah; Mark J Selna; Ronald A Paulus; James M Walker
Journal:  Health Aff (Millwood)       Date:  2007-01-26       Impact factor: 6.301

4.  Model Misspecification When Excluding Instrumental Variables From PS Models in Settings Where Instruments Modify the Effects of Covariates on Treatment.

Authors:  Richard Wyss; Alan R Ellis; Mark Lunt; M Alan Brookhart; Robert J Glynn; Til Stürmer
Journal:  Epidemiol Methods       Date:  2014-12

5.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Reduction of sampling bias of odds ratios for vertebral fractures using propensity scores.

Authors:  Y Lu; H Jin; M-H Chen; C C Glüer
Journal:  Osteoporos Int       Date:  2005-12-21       Impact factor: 4.507

7.  Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.

Authors:  Goodarz Danaei; Luis A García Rodríguez; Oscar Fernández Cantero; Roger Logan; Miguel A Hernán
Journal:  Stat Methods Med Res       Date:  2011-10-19       Impact factor: 3.021

8.  Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Authors:  Zeina A Habib; Leonidas Tzogias; Suzanne L Havstad; Karen Wells; George Divine; David E Lanfear; Jeffrey Tang; Richard Krajenta; Manel Pladevall; L Keoki Williams
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-06       Impact factor: 2.890

Review 9.  Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research.

Authors:  Jeff Y Yang; Michael Webster-Clark; Jennifer L Lund; Robert S Sandler; Evan S Dellon; Til Stürmer
Journal:  Gastrointest Endosc       Date:  2019-04-30       Impact factor: 9.427

10.  Does knee replacement surgery for osteoarthritis improve survival? The jury is still out.

Authors:  Devyani Misra; Na Lu; David Felson; Hyon K Choi; John Seeger; Thomas Einhorn; Tuhina Neogi; Yuqing Zhang
Journal:  Ann Rheum Dis       Date:  2016-05-17       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.